0001209191-22-001621.txt : 20220105 0001209191-22-001621.hdr.sgml : 20220105 20220105160041 ACCESSION NUMBER: 0001209191-22-001621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gharib Samir M. CENTRAL INDEX KEY: 0001533302 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 22511030 MAIL ADDRESS: STREET 1: 2655 PINE STREET STREET 2: #6 CITY: SAN FRANCISCO STATE: CA ZIP: 94115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 294-1687 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-31 0 0001683553 SPRUCE BIOSCIENCES, INC. SPRB 0001533302 Gharib Samir M. 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 DALY CITY CA 94014 0 1 0 0 President & CFO Common Stock 2021-12-31 5 J 0 E 2220 3.791 A 4632 D Employee Stock Option (right to buy) 4.59 2022-01-03 4 A 0 70000 0.00 A 2032-01-02 Common Stock 70000 70000 D Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code. 1/48th of the shares vest on a monthly basis from January 3, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). /s/ Samir Gharib 2022-01-05